Hyperion Completes First-in-Human Study of Ivy Robotic Vascular Access Platform
Hyperion Surgical has successfully completed the world's first robotic-assisted intravenous (IV) catheterization using its Ivy platform.
The Ivy platform integrates advanced imaging, AI, and robotic precision to enable a no-touch approach to IV placements.
- Performed by Miami-based Hyperion's clinical team in a first-in-human clinical study.
- Marks the first clinical use of a robotic-assisted system for peripheral IV catheterization.
Hyperion aims for Ivy to address the long-standing clinical challenge of high variability and failure rate in IV placements.
Its design enables the placement of the catheter — not just the needle — into the blood vessel.
Author's summary: Hyperion completes first-in-human study for robotic IV catheterization.